Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Brazil's RedeRio to hone key techs policy:

This article was originally published in Clinica

Executive Summary

RedeRio, an R&D network centred in Rio de Janeiro state, is Brazil's latest initiative to hone policy in key areas of medtech use. The network comprises leading R&D institutes and hospitals in the areas of orthopaedics (INTO), cardiology (INCL), cancer (INCA) and infant-maternal care (such as Hospital de Ipanema). Its first task will be to "assess the potential of the installations and equipment of the hospitals and institutes involved", said the health ministry. RedeRio's input will be used to support policy affecting the national delivery of so-called mid- to high-complexity care, currently worth an estimated R$17bn (US$7.9m) of the R$22bn budgeted for primary care. Cardiology high-complexity care alone has a R$800m budget.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT053502

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel